The value of prostate-specific antigen in the management of localized prostatic cancer.

P. C. Walsh, J. E. Oesterling, J. I. Epstein, D. J. Bruzek, R. C. Rock, D. W. Chan

Research output: Contribution to journalArticle


Prostate-specific antigen has proven to be a new useful marker for the evaluation of men with prostatic cancer. In addition to its proven value for immunohistochemical staining and for the followup evaluation of men treated with hormonal therapy, the monoclonal immunoradiometric assay for PSA has proven to be a unique, sensitive, and specific marker for the followup evaluation of men who have undergone radical prostatectomy.

Original languageEnglish (US)
Pages (from-to)27-33
Number of pages7
JournalProgress in clinical and biological research
StatePublished - 1989


ASJC Scopus subject areas

  • Medicine(all)

Cite this